Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.


Investor type Private Equity Firm


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 15
Average round size
The average size of a deal this fund participated in
Portfolio companies 11
Rounds per year 0.79
Lead investments 3
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 7
Key employees 6
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Personal Health
  • Consulting

In 2003 was created VINCI CAPITAL, which is appeared as VC. The fund was located in Europe if to be more exact in Switzerland. The main office of represented VC is situated in the Lausanne.

We also calculated 6 valuable employees in our database.

Among the most popular fund investment industries, there are Software, Food and Beverage. For fund there is a match between the location of its establishment and the land of its numerous investments - Switzerland. The fund has exact preference in some founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Addex Therapeutics, Anergis, Beqom

The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2019. The fund is constantly included in less than 2 investment rounds annually. This VINCI CAPITAL works on 11 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2009. Speaking about the real fund results, this VC is 7 percentage points more often commits exit comparing to other organizations.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the VINCI CAPITAL, startups are often financed by Novartis Venture Fund, Dansk Innovation, BioMedPartners. The meaningful sponsors for the fund in investment in the same round are Wellington Partners, Swisscom Ventures, BioMedPartners. In the next rounds fund is usually obtained by Wellington Partners, Swisscom Ventures, Renaissance PME Foundation.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of VINCI CAPITAL:
Typical Co-investors
VINCI CAPITAL is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after VINCI CAPITAL:

Funds with similar focus

Funds from Switzerland
Funds with similar focus located in Switzerland:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Bajaj Auto Finance India, Maharashtra, Pune
BridgeWest England, London, United Kingdom
Corning Technology Ventures Boston, Massachusetts, United States
Day One Entrepreneurs & Partners France, Ile-de-France, Paris
Dazhong Ziben China, Shanghai
GSR China, Hong Kong, Hong Kong Island
Hartree Partners New York, New York, United States
Hnap -
HSBC Bank Illinois, Lake Forest, United States
InNEVenture Fund -
Legend Ventures Bethesda, Maryland, United States
Lianchuang Donglin Chengdu, China, Sichuan
Maizijinfu China, Shanghai
Next Wave Impact Colorado, Denver, United States
Ningbo Meishan Baoshui Gangqu Tongli Zhicheng Touzi China, Ningbo Shi, Zhejiang
Osage Venture Partners Bala Cynwyd, Pennsylvania, United States
ReliaStar Financial Corp Minneapolis, Minnesota, United States
Seven-Eleven Japan Japan, Tokyo
Vanho Securities China, Guangdong, Shenzhen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Enterprise Software
Human Resources
$10M01 Apr 2014 Fribourg, Switzerland


Health Care
Life Science
Personal Health
$8M07 Feb 2014 Vaud, Switzerland


Emergency Medicine
Health Care
Medical Device
Personal Health
$18M09 Oct 2012 Lausanne, Vaud, Switzerland


Health Care
Life Science
Personal Health
$20M28 Mar 2011 Vaud, Switzerland


Enterprise Resource Planning (ERP)
$4M02 Feb 2010 Bern, Switzerland


Food and Beverage
Health Care
$27M11 Dec 2009 Aargau, Switzerland


Food and Beverage
Health Care
$30M22 Oct 2009 Aargau, Switzerland


Health Care
$21M01 Jul 2009 Vaud, Switzerland

Omnisens SA

Oil and Gas
Optical Communication
Renewable Energy
$5M10 Sep 2008 Vaud, Switzerland


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent VINCI CAPITAL?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: